Sarepta Therapeutics’ $313.5 Million Convertible Senior Notes Exchange

Martina Bellini North America Legal Chronicle
Tagged:

Ropes & Gray advised Sarepta Therapeutics on the deal.Sarepta Therapeutics, Inc. announced separate, privately negotiated exchange agreements with certain holders of its 1.50% Convertible Senior Notes…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here